Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 129

1.

Atomoxetine improved response inhibition in adults with attention deficit/hyperactivity disorder.

Chamberlain SR, Del Campo N, Dowson J, Müller U, Clark L, Robbins TW, Sahakian BJ.

Biol Psychiatry. 2007 Nov 1;62(9):977-84. Epub 2007 Jul 17.

PMID:
17644072
[PubMed - indexed for MEDLINE]
2.

Atomoxetine improved attention in children and adolescents with attention-deficit/hyperactivity disorder and dyslexia in a 16 week, acute, randomized, double-blind trial.

Wietecha L, Williams D, Shaywitz S, Shaywitz B, Hooper SR, Wigal SB, Dunn D, McBurnett K.

J Child Adolesc Psychopharmacol. 2013 Nov;23(9):605-13. doi: 10.1089/cap.2013.0054. Epub 2013 Nov 9.

PMID:
24206099
[PubMed - indexed for MEDLINE]
3.

Atomoxetine modulates right inferior frontal activation during inhibitory control: a pharmacological functional magnetic resonance imaging study.

Chamberlain SR, Hampshire A, Müller U, Rubia K, Del Campo N, Craig K, Regenthal R, Suckling J, Roiser JP, Grant JE, Bullmore ET, Robbins TW, Sahakian BJ.

Biol Psychiatry. 2009 Apr 1;65(7):550-5. doi: 10.1016/j.biopsych.2008.10.014. Epub 2008 Nov 20.

PMID:
19026407
[PubMed - indexed for MEDLINE]
4.

Atomoxetine: a review of its use in attention-deficit hyperactivity disorder in children and adolescents.

Garnock-Jones KP, Keating GM.

Paediatr Drugs. 2009;11(3):203-26. doi: 10.2165/00148581-200911030-00005. Review.

PMID:
19445548
[PubMed - indexed for MEDLINE]
5.

Modafinil improves cognition and response inhibition in adult attention-deficit/hyperactivity disorder.

Turner DC, Clark L, Dowson J, Robbins TW, Sahakian BJ.

Biol Psychiatry. 2004 May 15;55(10):1031-40.

PMID:
15121488
[PubMed - indexed for MEDLINE]
6.

Randomized clinical study of a histamine H3 receptor antagonist for the treatment of adults with attention-deficit hyperactivity disorder.

Weisler RH, Pandina GJ, Daly EJ, Cooper K, Gassmann-Mayer C; 31001074-ATT2001 Study Investigators.

CNS Drugs. 2012 May 1;26(5):421-34. doi: 10.2165/11631990-000000000-00000.

PMID:
22519922
[PubMed - indexed for MEDLINE]
7.

Differential effects of atomoxetine on executive functioning and lexical decision in attention-deficit/hyperactivity disorder and reading disorder.

de Jong CG, Van De Voorde S, Roeyers H, Raymaekers R, Allen AJ, Knijff S, Verhelst H, Temmink AH, Smit LM, Rodriques-Pereira R, Vandenberghe D, van Welsen I, ter Schuren L, Al-Hakim M, Amin A, Vlasveld L, Oosterlaan J, Sergeant JA.

J Child Adolesc Psychopharmacol. 2009 Dec;19(6):699-707. doi: 10.1089/cap.2009.0029.

PMID:
20035588
[PubMed - indexed for MEDLINE]
8.

Atomoxetine treatment of attention-deficit/hyperactivity disorder in young adults with assessment of functional outcomes: a randomized, double-blind, placebo-controlled clinical trial.

Durell TM, Adler LA, Williams DW, Deldar A, McGough JJ, Glaser PE, Rubin RL, Pigott TA, Sarkis EH, Fox BK.

J Clin Psychopharmacol. 2013 Feb;33(1):45-54. doi: 10.1097/JCP.0b013e31827d8a23.

PMID:
23277268
[PubMed - indexed for MEDLINE]
9.

Modafinil improves cognition and attentional set shifting in patients with chronic schizophrenia.

Turner DC, Clark L, Pomarol-Clotet E, McKenna P, Robbins TW, Sahakian BJ.

Neuropsychopharmacology. 2004 Jul;29(7):1363-73.

PMID:
15085092
[PubMed - indexed for MEDLINE]
Free Article
10.

A head-to-head randomized clinical trial of methylphenidate and atomoxetine treatment for executive function in adults with attention-deficit hyperactivity disorder.

Ni HC, Shang CY, Gau SS, Lin YJ, Huang HC, Yang LK.

Int J Neuropsychopharmacol. 2013 Oct;16(9):1959-73. doi: 10.1017/S1461145713000357. Epub 2013 May 14.

PMID:
23672818
[PubMed - indexed for MEDLINE]
11.

A randomized controlled trial investigation of a non-stimulant in attention deficit hyperactivity disorder (ACTION): rationale and design.

Tsang TW, Kohn MR, Hermens DF, Clarke SD, Clark CR, Efron D, Cranswick N, Lamb C, Williams LM.

Trials. 2011 Mar 13;12:77. doi: 10.1186/1745-6215-12-77.

PMID:
21396130
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Atomoxetine: a review of its use in adults with attention deficit hyperactivity disorder.

Simpson D, Plosker GL.

Drugs. 2004;64(2):205-22. Review.

PMID:
14717619
[PubMed - indexed for MEDLINE]
13.

Once-daily atomoxetine for adult attention-deficit/hyperactivity disorder: a 6-month, double-blind trial.

Adler LA, Spencer T, Brown TE, Holdnack J, Saylor K, Schuh K, Trzepacz PT, Williams DW, Kelsey D.

J Clin Psychopharmacol. 2009 Feb;29(1):44-50. doi: 10.1097/JCP.0b013e318192e4a0.

PMID:
19142107
[PubMed - indexed for MEDLINE]
14.

Spotlight on atomoxetine in adults with attention-deficit hyperactivity disorder.

Simpson D, Plosker GL.

CNS Drugs. 2004;18(6):397-401. Review.

PMID:
15089111
[PubMed - indexed for MEDLINE]
15.

[Atomoxetine: a new treatment for Attention Deficit/Hyperactivity Disorder (ADHD) in children and adolescents].

Purper-Ouakil D, Fourneret P, Wohl M, Rénéric JP.

Encephale. 2005 May-Jun;31(3):337-48. Review. French.

PMID:
16142049
[PubMed - indexed for MEDLINE]
16.

Neurofunctional effects of methylphenidate and atomoxetine in boys with attention-deficit/hyperactivity disorder during time discrimination.

Smith A, Cubillo A, Barrett N, Giampietro V, Simmons A, Brammer M, Rubia K.

Biol Psychiatry. 2013 Oct 15;74(8):615-22. doi: 10.1016/j.biopsych.2013.03.030. Epub 2013 May 31.

PMID:
23731741
[PubMed - indexed for MEDLINE]
17.

Similar effects of the selective noradrenaline reuptake inhibitor atomoxetine on three distinct forms of impulsivity in the rat.

Robinson ES, Eagle DM, Mar AC, Bari A, Banerjee G, Jiang X, Dalley JW, Robbins TW.

Neuropsychopharmacology. 2008 Apr;33(5):1028-37. Epub 2007 Jul 18.

PMID:
17637611
[PubMed - indexed for MEDLINE]
Free Article
18.

Improving visual memory, attention, and school function with atomoxetine in boys with attention-deficit/hyperactivity disorder.

Shang CY, Gau SS.

J Child Adolesc Psychopharmacol. 2012 Oct;22(5):353-63. doi: 10.1089/cap.2011.0149.

PMID:
23083022
[PubMed - indexed for MEDLINE]
19.

Correlates of alcohol use in adults with ADHD and comorbid alcohol use disorders: exploratory analysis of a placebo-controlled trial of atomoxetine.

Wilens TE, Adler LA, Tanaka Y, Xiao F, D'Souza DN, Gutkin SW, Upadhyaya HP.

Curr Med Res Opin. 2011 Dec;27(12):2309-20. doi: 10.1185/03007995.2011.628648. Epub 2011 Oct 27.

PMID:
22029549
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Safety of atomoxetine in combination with intravenous cocaine in cocaine-experienced participants.

Cantilena L, Kahn R, Duncan CC, Li SH, Anderson A, Elkashef A.

J Addict Med. 2012 Dec;6(4):265-73. doi: 10.1097/ADM.0b013e31826b767f.

PMID:
22987022
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk